Commitments and Contingencies (Details) |
6 Months Ended | |||
|---|---|---|---|---|
|
Dec. 31, 2019
USD ($)
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2025
USD ($)
|
Jun. 30, 2026
ILS (₪)
|
|
| Commitments and Contingencies (Details) [Line Items] | ||||
| Research and development | $ 962,705 | $ 1,155,436 | ||
| Royalties payment | 9,000 | |||
| Long-term restricted deposits held in bank | $ 86,467 | ₪ 257,500 | ||
| Bank of Israel [Member] | ||||
| Commitments and Contingencies (Details) [Line Items] | ||||
| Bear interest rate | 0.72% | 0.72% | ||
| Israel Innovation Authority [Member] | ||||
| Commitments and Contingencies (Details) [Line Items] | ||||
| Research and development grant received | 300.00% | |||
| Research and development | $ 738,000 | |||
| Grant received | $ 575,000 | |||
| Minimum [Member] | Israel Innovation Authority [Member] | ||||
| Commitments and Contingencies (Details) [Line Items] | ||||
| Pay royalties rate | 3.00% | |||
| Maximum [Member] | Israel Innovation Authority [Member] | ||||
| Commitments and Contingencies (Details) [Line Items] | ||||
| Pay royalties rate | 3.50% | |||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Percentage of royalties rate on sales. No definition available.
|
| X | ||||||||||
- Definition Research and development grant received. No definition available.
|
| X | ||||||||||
- Definition The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of cash paid for royalties during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of the carrying amount of short-term borrowings outstanding as of the balance sheet date which accrues interest at a set, unchanging rate. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|